Agendia, MD Anderson, Netherlands Cancer Institute Partner on Colorectal Cancer Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agendia is partnering with the University of Texas MD Anderson Cancer Center and the Netherlands Cancer Institute to use genomics and proteomics to better understand the biology of colorectal cancer, the Dutch firm announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."